Aurobindo Pharma has incorporated a new wholly-owned subsidiary named Aurobindo Pharma Philippines Inc. in the Philippines. This entity was created by Aurobindo’s subsidiary, Helix Healthcare B.V., on January 23, 2026. The purpose of this new subsidiary is to expand Aurobindo’s pharmaceutical business in the Philippines.
Philippines Expansion
Aurobindo Pharma, through its wholly-owned subsidiary Helix Healthcare B.V., has established a new wholly-owned subsidiary, Aurobindo Pharma Philippines Inc., in the Philippines. This incorporation was finalized on January 23, 2026.
Subsidiary Details
The new subsidiary has an initial share capital of PESO 120,000,000 (approximately $2,000,000 USD), divided into 1,200,000 shares with a nominal value of 100 PESO per share. Aurobindo Pharma controls 100% of the shares.
Strategic Rationale
The establishment of Aurobindo Pharma Philippines Inc. aims to broaden Aurobindo Pharma’s market presence and expand its pharmaceutical product business within the Philippines.
Source: BSE
